New incident report
Incident Report Number: 2024-1478
Registrant Reference Number: 2024-CA-000005
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 200 Plaza Drive, Suite 402
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 30734 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Flea and Tick Drops for Dogs 14 - 28 kg
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Dog / Chien
German Shepherd/Sheepdog (unspecified) crossbred
1
Female
7
Unknown
Skin
>1 mo <= 6 mos / > 1 mois < = 6 mois
>1 mo <=2 mos / > 1 mois < = 2 mois
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 14-Dec-2023, a 7 year old, neutered, female, German Shepherd/Sheepdog (Unspecified) crossbred dog, of unknown weight, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of Hartz UltraGuard Flea and Tick Drops for Dogs 14 - 28 kg (Phenothrin (Sumithrin)) via the topical route by the animal owner. It was unknown if the product was used correctly as the dog's weight was unknown. The product was applied to the dog once before on 14-Nov-2023 with no adverse effects noted. On 31-Dec-2023, the dog developed a rash localized to the abdomen and application site pruritus (biting at the application site). The dog was bathed with an unspecified human shampoo and administered an unspecified rash cream by the animal owner. The clinical signs improved but continued. Bathing the dog with dish soap for product removal was recommended. If signs persisted, veterinary evaluation was also recommended. No further information was received.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.